Evidence map›Paper›PMID 42146859›Full record

ArticleBiomaterial investigations in dentistry2026

Cytotoxicity evaluation of different clear aligner systems on human primary gingival fibroblasts: an in vitro study.

Rituparna Pronajit Das, Parag Vishnu Gangurde, Alok Ranjan, Shashank Sharad Gaikwad, Hitesh Ramdas Sawant, Manav Karia

Abstract read
In one paragraph

Article in Biomaterial investigations in dentistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Rituparna Pronajit DasBharati Vidyapeeth (Deemed to be University) Dental College and Hospital, Navi Mumbai, India.
Parag Vishnu GangurdeOrthodontics and Dentofacial Orthopaedics, Bharati Vidyapeeth (Deemed to be University) Dental College and Hospital, Navi Mumbai, India.
Alok RanjanOrthodontics and Dentofacial Orthopaedics, Bharati Vidyapeeth (Deemed to be University) Dental College and Hospital, Navi Mumbai, India.
Shashank Sharad GaikwadOrthodontics and Dentofacial Orthopaedics, Bharati Vidyapeeth (Deemed to be University) Dental College and Hospital, Navi Mumbai, India.
Hitesh Ramdas SawantOrthodontics and Dentofacial Orthopaedics, Bharati Vidyapeeth (Deemed to be University) Dental College and Hospital, Navi Mumbai, India.
Manav KariaOrthodontics and Dentofacial Orthopaedics, Bharati Vidyapeeth (Deemed to be University) Dental College and Hospital, Navi Mumbai, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Clear aligners, widely adopted in modern orthodontics, are designed to stay in constant contact with the oral mucosa for extended durations. Persistent concerns exist about the possible leaching of cytotoxic agents like bisphenol-A from these materials, which have heightened the need for rigorous biocompatibility evaluation. Among various assays, the MTT (3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide) assay is a reliable in vitro method, which assesses metabolic activity and cell viability, making it a gold standard for cytotoxicity screening. Objective: The objective was to assess and contrast the potential cell-damaging effects of three different clear aligner brands - Invisalign Methods: Aligner pellets were immersed in normal saline for 30 days at 37°C. Eluents were diluted to 5, 10, and 20% concentrations. HGFs were exposed to these eluents for 48 hours, and cytotoxicity was assessed via MTT assay. To assess the survival rate of the cells, light absorbance was recorded at a wavelength of 570 nanometers. Results: Invisalign Conclusion: Material composition critically influences cytotoxicity. Invisalign

Indexed as

biocompatibilityclear alignerscytotoxicityhuman gingival fibroblastsMTT assay

Identifiers

PMID42146859
PMCPMC13176899

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.